Anbio Biotechnology (NNNN) Assets Average (2024 - 2025)
Anbio Biotechnology (NNNN) recorded quarterly Assets Average of $13840.3 billion in Q4 2025, little changed quarter-over-quarter from $13840.3 billion in Q2 2025, and up 79694093.8% on a YoY basis from N/an in Q4 2024.
Anbio Biotechnology (NNNN) Assets Average (2024 - 2025) Analysis & Trends
Anbio Biotechnology's Assets Average history runs 2 years deep, the most recent figure standing at $13840.3 billion for Q4 2025.
- In Q4 2025, Assets Average rose 79694093.8% year-over-year to $13840.3 billion; the TTM figure through Dec 2025 stood at $13840.3 billion (up 79694093.8% YoY), while the FY2025 annual figure was $24.6 million, up 41.55% from the prior year.
- Assets Average was $13840.3 billion for Q4 2025 at Anbio Biotechnology, roughly flat from $13840.3 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $13840.3 billion in Q4 2025 to a low of $17.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.28 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 52.84 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 38.75 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.64 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.19 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.20 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.45 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.27 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.95 Bn |
| 10 | Anbio Biotechnology | 720.59 Mn | 708.69 Mn | - | 13,840.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,840.31 Bn |
| Jun 30, 2025 | 13,840.31 Bn |
| Dec 31, 2024 | 17.37 Mn |